Related Experiment Video

Updated: Sep 10, 2025

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
08:42

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Published on: July 18, 2008

16.2K

Response to letter to Editor on "Circulating cell-free DNA as predictors of Parkinson's disease"

Simon Geir Møller1

  • 1Department of Biological Sciences, St. John's University, New York, NY, USA; WalCado Labs Inc. New York, USA.

Parkinsonism & Related Disorders
|August 26, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Independent validationcfDNA

More Related Videos

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.2K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Related Experiment Videos

Last Updated: Sep 10, 2025

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
08:42

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Published on: July 18, 2008

16.2K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.2K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
Neural Regulation01:37

Neural Regulation

39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K

Articles linked to this work by shared authors, journal, and citation graph.

Circulating cell-free DNA as predictors of Parkinson's disease.

Parkinsonism & related disorders·2025

The Intersection of Parkinson's Disease, Viral Infections, and COVID-19.

Molecular neurobiology·2021

Protein biomarkers of neural system.

Journal of otology·2019

Combinatory microRNA serum signatures as classifiers of Parkinson's disease.

Parkinsonism & related disorders·2019

DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis.

Human molecular genetics·2017

Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress.

Antioxidants (Basel, Switzerland)·2017

Phenotypic and movement-dependent periodic and aperiodic activity in Parkinson's STN-LFP recordings.

Parkinsonism & related disorders·2026

Cortical myoclonus as a common and clinically actionable movement disorder phenotype of 22q11.2 deletion syndrome.

Parkinsonism & related disorders·2026

Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.

Parkinsonism & related disorders·2026

Dyskinesias induced by focused ultrasound subthalamotomy in Parkinson's disease are associated with better patient impression of change.

Parkinsonism & related disorders·2026

Redefining the accuracy of clinical diagnosis of Parkinson's disease: A systematic review and meta-analysis.

Parkinsonism & related disorders·2026

Women with Parkinson's disease: exploring the occurrence of hormone-related symptom changes and associated care.

Parkinsonism & related disorders·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us